Fuso Pharmaceutical Industries: Corporate Governance Report 07/01/2024
Fuso Pharmaceutical Industries: Corporate Governance Report 07/01/2024
Fuso Pharmaceutical Industries: Announcements of individual stocks regarding the postponement of the announcement of the medium-term management strategy.
Fuso Pharmaceutical Industries: Interim report
Fuso Pharmaceutical Industries: Internal control report - 101st period (04/01/2023 - 03/31/2024)
Fuso Pharmaceutical Industries: Confirmation letter
Fuso Pharmaceutical Industries: Securities Report - 101st Fiscal Year (April 1, 2023 - March 31, 2024)
Fuso Pharmaceutical Industries: Notice of the 101st Annual General Meeting of Shareholders _2024_
Fuso Pharmaceutical Industries: 2024 Annual General Meeting of Shareholders Convocation Notice and Shareholders' Meeting Materials
Fuso Pharmaceutical Industries: (Correction) Partial Corrections to the “Notice Concerning the Conclusion of Syndicated Loan Agreements”
Fuso Pharmaceutical Industries: Extraordinary Report
Fuso Pharmaceutical Industries: Notice regarding the conclusion of a syndicated loan agreement
Fuso Pharmaceutical Industries: Summary of financial results for the fiscal year ending 2024/3 [Japanese GAAP] (unconsolidated)
Fuso Pharmaceutical Industries: Notice regarding the discontinuation of countermeasures (takeover defense measures) related to mass acquisitions of our shares
Fuso Pharmaceutical Industries: Progress status (compliance) based on plans aimed at complying with Prime Market listing maintenance standards
Fuso Pharmaceutical Industries: Change Report (Stock Certificates Eligible for Special Provisions, etc.)
Fuso Pharmaceutical Industries: Extraordinary Report
Fuso Pharmaceutical Industries: Notice regarding completion of payment and partial loss of rights of treasury stock as share incentives with transfer restrictions for employee shareholding associations
Fuso Pharmaceutical Industries: Notice regarding the petition for extension of the patent infringement injunction lawsuit against our company
Fuso Pharmaceutical: Large holding report (stock certificates subject to special cases, etc.)
No Data